Skip to main content

Kraig Biocraft Laboratories Delivers Ballistic Shootpack Panels to U.S. Army

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has delivered ballistic shootpack panels to the U.S. Army made from the Company’s proprietary Dragon Silk™ material. These panels will be evaluated for effectiveness in stopping bullets, in an effort to provide our warfighters with a lighter and more comfortable alternative to conventional protective apparel.

Dragon Silk is a genetically engineered spider silk which mimics the strength and toughness found in native spider silk, but which can be produced at large quantities through the Company’s specially developed silkworms. These specially engineered silkworms were developed to be a direct drop-in replacement into the traditional silk production infrastructure which produces more than 150,000 metric tons of silk per year. This approach of adapting the existing production infrastructure is the key differentiator between the Company and others working to produce spider silk materials.

Unlike traditional synthetic materials such as Ultra High Molecular Weight (UHMW) polymers or aramids, which are very stiff, spider silk is extremely flexible, making it more comfortable and providing higher mobility and movement for the wearer. Spider silk is also biocompatible, making it ideal for skin contact applications, and biodegradable, reducing the environmental burden of the current synthetic materials

“After years of research and investment, developing this ground breaking technology, we are very excited to now see it in the hands of the U.S. Army,” stated Jon Rice, COO. “For me, personally, and for the Company, the opportunity to help protect the brave men and women who dedicate themselves to our protection is a great honor.”

The Company continues to develop the next generation of high performance recombinant spider silk materials under the exercised contract option period authorized in 2017 and is currently in the process of opening a production facility in Vietnam to significantly expand its production capacity of Dragon Silk and its many other recombinant spider silk offerings.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Contacts:

Hansel Capital, LLC
Ben Hansel, (720) 288-8495
ir@KraigLabs.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.